Woo Ian Ying

Woo Ian Ying (chief executive) discloses dealings in Everest Medicines Ltd. to HKEX. Over a trading history stretching from 14 July 2021 to 30 June 2026, the count stands at 21 filings.

On the open market, the record shows 7 purchases worth €489k and 4 sales worth €171k. No amount is published for 9 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The latest filing, published on 19 August 2026, reports a transaction in Everest Medicines Ltd. The most recent open-market purchase was published on 16 December 2025, 312 days ago. Typically, a trade is published a median of 60 days after it takes place. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.